As HSD10 overexpression grants pheochromocytoma cells enhanced cellular proliferative and cell death resistant capabilities, targeted inhibition of HSD10 in cancer cells may provide a novel treatment method. Here, FSIP1 is linked to hereditary pheochromocytoma-paraganglioma.